LILRB2 is a neuronal cell surface receptor that interacts with Aβ and is being studied as a promising therapeutic target for AD [60, 61], while NOTCH1 has been found to be differentially expressed in Alzheimer's patients [62] and is potentially involved in neurodegeneration-related cell signaling disruptions [63]. This evidence concerns the gene LILRB2 and Alzheimer disease.